<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "ipilimumab inj VIAL>
<dose><value>3</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>ipilimumab inj VIAL</value>
</drugname><strength><value>5 mg/mL</value>
</strength><frequency><value>EVERY 3 WEEKS</value>
</frequency><instruction><value>for 4 doses. Administer dose over 30 minutes through an in-line 0.2 to 0.22 micron filter. If patient has experienced a prior infusion reaction, adminster all subsequent infusions over 90 minutes.</value>
</instruction><volume><value>10 mL</value>
<value>40 mL</value>
</volume><units><value>mg/kg</value>
</units><additionalnotes><value>If bilirubin is greater than 1.5 X upper limit normal or ALT or AST greater than 2.5 X upper limit normal: Hold treatment and contact prescriber. Doses are either delayed or discontinued for toxicity, doses are not reduced.</value>
</additionalnotes><population><value>ADULT</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=7441</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary with Restrictions.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>